126 related articles for article (PubMed ID: 15127453)
1. In pursuit of carbohydrate-based HIV vaccines, part 2: The total synthesis of high-mannose-type gp120 fragments--evaluation of strategies directed to maximal convergence.
Geng X; Dudkin VY; Mandal M; Danishefsky SJ
Angew Chem Int Ed Engl; 2004 May; 43(19):2562-5. PubMed ID: 15127453
[No Abstract] [Full Text] [Related]
2. In pursuit of carbohydrate-based HIV vaccines, part 1: The total synthesis of hybrid-type gp120 fragments.
Mandal M; Dudkin VY; Geng X; Danishefsky SJ
Angew Chem Int Ed Engl; 2004 May; 43(19):2557-61. PubMed ID: 15127452
[No Abstract] [Full Text] [Related]
3. Toward fully synthetic carbohydrate-based HIV antigen design: on the critical role of bivalency.
Dudkin VY; Orlova M; Geng X; Mandal M; Olson WC; Danishefsky SJ
J Am Chem Soc; 2004 Aug; 126(31):9560-2. PubMed ID: 15291558
[TBL] [Abstract][Full Text] [Related]
4. Binding of high-mannose-type oligosaccharides and synthetic oligomannose clusters to human antibody 2G12: implications for HIV-1 vaccine design.
Wang LX; Ni J; Singh S; Li H
Chem Biol; 2004 Jan; 11(1):127-34. PubMed ID: 15113002
[TBL] [Abstract][Full Text] [Related]
5. Reactivity-based one-pot synthesis of oligomannoses: defining antigens recognized by 2G12, a broadly neutralizing anti-HIV-1 antibody.
Lee HK; Scanlan CN; Huang CY; Chang AY; Calarese DA; Dwek RA; Rudd PM; Burton DR; Wilson IA; Wong CH
Angew Chem Int Ed Engl; 2004 Feb; 43(8):1000-3. PubMed ID: 14966891
[No Abstract] [Full Text] [Related]
6. Chemoenzymatic synthesis of high-mannose type HIV-1 gp120 glycopeptides.
Singh S; Ni J; Wang LX
Bioorg Med Chem Lett; 2003 Feb; 13(3):327-30. PubMed ID: 12565922
[TBL] [Abstract][Full Text] [Related]
7. Toward a carbohydrate-based HIV-1 vaccine: synthesis and immunological studies of oligomannose-containing glycoconjugates.
Ni J; Song H; Wang Y; Stamatos NM; Wang LX
Bioconjug Chem; 2006; 17(2):493-500. PubMed ID: 16536482
[TBL] [Abstract][Full Text] [Related]
8. Preparation of synthetic glycoconjugates as potential vaccines against Shigella flexneri serotype 2a disease.
Wright K; Guerreiro C; Laurent I; Baleux F; Mulard LA
Org Biomol Chem; 2004 May; 2(10):1518-27. PubMed ID: 15136809
[TBL] [Abstract][Full Text] [Related]
9. Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12.
Pashov A; MacLeod S; Saha R; Perry M; VanCott TC; Kieber-Emmons T
Glycobiology; 2005 Oct; 15(10):994-1001. PubMed ID: 15917430
[TBL] [Abstract][Full Text] [Related]
10. Chemoenzymatic synthesis of neoglycoproteins using transglycosylation with endo-beta-N-acetylglucosaminidase A.
Fujita K; Takegawa K
Biochem Biophys Res Commun; 2001 Apr; 282(3):678-82. PubMed ID: 11401514
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of new polyether glycodendrons as oligosaccharide mimetics.
Elsner K; Boysen MM; Lindhorst TK
Carbohydr Res; 2007 Sep; 342(12-13):1715-25. PubMed ID: 17555733
[TBL] [Abstract][Full Text] [Related]
12. Toward oligosaccharide- and glycopeptide-based HIV vaccines.
Wang LX
Curr Opin Drug Discov Devel; 2006 Mar; 9(2):194-206. PubMed ID: 16566290
[TBL] [Abstract][Full Text] [Related]
13. On-resin convergent synthesis of a glycopeptide from HIV gp120 containing a high mannose type N-linked oligosaccharide.
Chen R; Tolbert TJ
Methods Mol Biol; 2011; 751():343-55. PubMed ID: 21674342
[TBL] [Abstract][Full Text] [Related]
14. Rapid assembly of gp120 oligosaccharide moieties via one-pot glycosidation-deprotection sequences.
Pastore A; Adinolfi M; Iadonisi A; Valerio S
Carbohydr Res; 2010 Jul; 345(10):1316-23. PubMed ID: 20334854
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a synthetic vaccine construct as antigen for the detection of HIV-induced humoral responses.
Hewer R; Meyer D
Vaccine; 2005 Mar; 23(17-18):2164-7. PubMed ID: 15755588
[TBL] [Abstract][Full Text] [Related]
16. American Chemical Society meeting. Arraymaker speeds analyses by months.
Service RF
Science; 2003 Oct; 302(5642):47. PubMed ID: 14526057
[No Abstract] [Full Text] [Related]
17. Synthesis of high-mannose 1-thio glycans and their conjugation to protein.
Bailey JJ; Bundle DR
Org Biomol Chem; 2014 Apr; 12(14):2193-213. PubMed ID: 24549150
[TBL] [Abstract][Full Text] [Related]
18. Chemoenzymatic synthesis of HIV-1 V3 glycopeptides carrying two N-glycans and effects of glycosylation on the peptide domain.
Li H; Li B; Song H; Breydo L; Baskakov IV; Wang LX
J Org Chem; 2005 Nov; 70(24):9990-6. PubMed ID: 16292832
[TBL] [Abstract][Full Text] [Related]
19. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
Bower JF; Green TD; Ross TM
Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849
[TBL] [Abstract][Full Text] [Related]
20. Toward solution-phase automated iterative synthesis: fluorous-tag assisted solution-phase synthesis of linear and branched mannose oligomers.
Jaipuri FA; Pohl NL
Org Biomol Chem; 2008 Aug; 6(15):2686-91. PubMed ID: 18633525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
